scholarly article | Q13442814 |
P356 | DOI | 10.1002/JMV.2102 |
P698 | PubMed publication ID | 11745943 |
P50 | author | Devra Davis | Q5267942 |
Jonathan L. Heeney | Q39066258 | ||
P2093 | author name string | van der Groen G | |
Kestens L | |||
Janssens W | |||
Heyndrickx L | |||
Willems B | |||
Ondoa P | |||
Coppens S | |||
van der Berg I | |||
P2860 | cites work | Isolation of simian immunodeficiency viruses from two sooty mangabeys in Côte d'Ivoire: virological and genetic characterization and relationship to other HIV type 2 and SIVsm/mac strains | Q39346434 |
Virological and polymerase chain reaction studies of HIV-1/HIV-2 dual infection in Côte d'Ivoire | Q39346459 | ||
High levels of viral replication during primary simian immunodeficiency virus SIVagm infection are rapidly and strongly controlled in African green monkeys | Q39592712 | ||
In Vivo Sequence Variation of the Human Immunodeficiency Virus Type 1envGene: Evidence for Recombination Among Variants Found in a Single Individual | Q43661193 | ||
Broad cross-neutralizing activity in serum is associated with slow progression and low risk of transmission in primate lentivirus infections | Q44138263 | ||
Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant | Q45018234 | ||
Neutralization escape in human immunodeficiency virus type 1-infected long-term nonprogressors | Q45750292 | ||
The evolutionary rate of nonpathogenic simian immunodeficiency virus (SIVagm) is in agreement with a rapid and continuous replication in vivo | Q45768259 | ||
Systematic identification of T-cell activating epitopes on the human immunodeficiency virus type 1 envelope glycoprotein gp120 in primates immunized with synthetic peptides | Q45786781 | ||
Quantitation of human immunodeficiency virus type 1 in the blood of infected persons | Q45844274 | ||
V3 seroreactivity and sequence variation: tracking the emergence of V3 genotypic variation in HIV-1-infected patients. | Q49126722 | ||
Autologous neutralizing antibodies to SIVsm in cynomolgus monkeys correlate to prognosis. | Q54225799 | ||
Recombination in HIV-1 | Q57998149 | ||
Neutralizing antibodies are positively associated with CD4+ T-cell counts and T-cell function in long-term AIDS-free infection | Q77386243 | ||
Recombination in AIDS viruses | Q22252829 | ||
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice | Q24286950 | ||
Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection | Q28304764 | ||
Sequence analysis of a highly divergent HIV-1-related lentivirus isolated from a wild captured chimpanzee | Q30423988 | ||
Immune and hematopoietic parameters in HIV-1-infected chimpanzees during clinical progression toward AIDS. | Q33500138 | ||
A dual infection/competition assay shows a correlation between ex vivo human immunodeficiency virus type 1 fitness and disease progression | Q33604871 | ||
Human immunodeficiency virus (HIV)-positive sera obtained shortly after seroconversion neutralize autologous HIV type 1 isolates on primary macrophages but not on lymphocytes | Q33805324 | ||
Wide range of viral load in healthy african green monkeys naturally infected with simian immunodeficiency virus | Q33812785 | ||
Genetic organization of a chimpanzee lentivirus related to HIV-1. | Q34028341 | ||
Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein | Q34301897 | ||
Enhancement of human immunodeficiency virus type 1 infection by antisera to peptides from the envelope glycoproteins gp120/gp41 | Q36230737 | ||
Convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type 1 within a single infected patient | Q37031589 | ||
Phenotypic and functional parameters of cellular immunity in a chimpanzee with a naturally acquired simian immunodeficiency virus infection | Q38575178 | ||
Design and evaluation of an in-house HIV-1 (group M and O), SIVmnd and SIVcpz antigen capture assay | Q38900270 | ||
Virologic and serologic characteristics of a natural chimpanzee lentivirus infection | Q39346423 | ||
P433 | issue | 4 | |
P921 | main subject | chimpanzee | Q4126704 |
P304 | page(s) | 765-776 | |
P577 | publication date | 2001-12-01 | |
P1433 | published in | Journal of Medical Virology | Q15716684 |
P1476 | title | Genetic variability of the V1 and V2 env domains of SIVcpz-ant and neutralization pattern of plasma viruses in a chimpanzee infected naturally | |
P478 | volume | 65 |
Q33393641 | Characterization of a new simian immunodeficiency virus strain in a naturally infected Pan troglodytes troglodytes chimpanzee with AIDS related symptoms |
Q54220425 | Characterization of twin-cysteine motif in the V2-loop region of gp120 in primate lentiviruses. |
Q31034710 | Evolution of the uniquely adaptable lentiviral envelope in a natural reservoir host |
Q30332744 | Genetic recombination and its role in the development of the HIV-1 pandemic |
Q36246353 | Noninvasive follow-up of simian immunodeficiency virus infection in wild-living nonhabituated western lowland gorillas in Cameroon |
Q36667567 | Single real-time reverse transcription-PCR assay for detection and quantification of genetically diverse HIV-1, SIVcpz, and SIVgor strains |
Q58395217 | The Evolution of Resistance to Simian Immunodeficiency Virus (SIV): A Review |
Q34717558 | Transmission of simian immunodeficiency virus SIVcpz and the evolution of infection in the presence and absence of concurrent human immunodeficiency virus type 1 infection in chimpanzees |
Search more.